Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Should young patients with neuroblastoma receive high-dose platinum compounds?

April 26, 2017compounds high-dose neuroblastoma Patients Platinum young

0

Posted

Should young patients with neuroblastoma receive high-dose platinum compounds?

1 Answer

0

Posted

Original article Kushner BH et al. (2006) Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer 107: 417–422 PubMedPlatinum compounds are the basis for induction and myeloablative strategies in neuroblastoma but can cause ototoxicity.